Crafting an Individual Treatment Plan for Patients With Prostate Cancer
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Watch
Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care
Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemo.
Working to Address Unmet Medical Needs in MPNs
CURE spoke with John Crispino, the director of the division of experimental hematology at St. Jude Children’s Research Hospital.
How to Best Navigate a Diagnosis of Lung and Head and Neck Cancer
Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.
Joy Anderson Reflects on Her Diagnosis of a Rare Blood Cancer
A push for answers led to a rare blood disorder diagnosis after Joy’s symptoms were initially dismissed.
Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T
Overcoming Barriers to Emotional and Physical Support in Cancer Care
An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression.
Raising Awareness for Adolescents and Young Adults with Cancer
Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.
Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes
Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial.
Recognizing Symptoms During Head and Neck Cancer Awareness Month
Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.
Dr. Grivas Highlights Three Practice-Changing Trials in Bladder Cancer
Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three practice-changing phase 3 trials.
Raising Awareness on Multidisciplinary Approaches in GI Cancers
Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as per an expert.
Breaking Down The Use of Rina-S in Advanced Ovarian Cancer
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Understanding Esophageal Cancer: Early Signs, Risks and Key Insights
Dr. Nataliya Uboha sat down to discuss the early warning signs of esophageal cancer, as well as important key takeaways for those with the disease.
Understanding How to Advance Immunotherapy Strategy Models in Melanoma
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Radiation Therapy Advances Improve Quality of Life for GI Cancer
Advancements in radiation therapy, including proton therapy and stereotactic radiation, reduce side effects and improve quality of life for GI cancer.
Early Detection Critical for Testicular Cancer in Young Men
April serves as Testicular Cancer Awareness Month, which is the most common type of cancer in men aged between 15 and 44 years old.
Phase 3 Trial Leads to FDA Approval of Cabometyx in Neuroendocrine Tumors
Based on the phase 3 CABINET trial, the FDA approved Cabometyx for some patients with previously treated neuroendocrine tumors.
A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients
Some cancer statistics may reflect 'backwards-looking data', making it important to stay up to date on reliable information and happenings in the space.
An Expert Breaks Down Lymphedema Following Cancer Care
Dr. Sheri Yolanda Prentiss discusses the importance of seeking early intervention to detect lymphedema following cancer care.
Early Detection and Screening is Key for Esophageal Cancer
Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.
Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.
Raising Awareness for Kidney Cancer and the Challenges Patients Face
It is important to recognize Kidney Cancer Awareness Month as a time to get involved, as more than 600,000 people in the U.S. live with kidney cancer.
Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.
How Biomarker Testing Can Shape a Breast Cancer Treatment Plan
Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.
Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
How Personalized Medicine May Impact Gastrointestinal Cancer Treatment
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Machine Learning Improves Transplant Risk Assessment in Myelofibrosis
Machine learning model improves transplant risk assessment for patients with myelofibrosis, helping clinicians make informed decisions, as per an expert.
Are You Worried About HER2+ Breast Cancer Recurrence?
Breaking Down Kidney Cancer Treatment Advancements and Providing Hope
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
